Hydroxychloroquine sulfate, Anti-inflammatory and antimalarial agent (ab120827)
Key features and details
- Anti-inflammatory and antimalarial agent
- CAS Number: 747-36-4
- Purity: > 99%
- Soluble in water to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Hydroxychloroquine sulfate, Anti-inflammatory and antimalarial agent -
Description
Anti-inflammatory and antimalarial agent -
Purity
> 99% -
CAS Number
747-36-4 -
Chemical structure
Properties
-
Chemical name
7-Chloro-4-[4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-methylbutylamino]quinoline sulfate -
Molecular weight
433.95 -
Molecular formula
C18H26ClN3O.H2SO4 -
Storage instructions
Store at -20°C. It is important to note that this product is reported to be light sensitive. Store In the Dark. Store under desiccating conditions. -
Solubility overview
Soluble in water to 100 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
Source
Synthetic
-
Research areas
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (3)
ab120827 has been referenced in 3 publications.
- Bhise N et al. Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus. Arch Virol 168:147 (2023). PubMed: 37115342
- Si L et al. A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng 5:815-829 (2021). PubMed: 33941899
- Miyamoto M et al. Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas. J Gynecol Oncol 28:e33 (2017). PubMed: 28382796